Binge Eating Disorder Symptoms – Pipeline Overview of Therapeutics Development in H1 2017

About This Presentation
Title:

Binge Eating Disorder Symptoms – Pipeline Overview of Therapeutics Development in H1 2017

Description:

Binge Eating Disorder- Pipeline Market Review, H1 2017 report provides an overview of the Binge Eating Disorder (Central Nervous System) pipeline landscape. The Binge Eating Disorder pipeline guide encapsulates all the dormant and discontinued pipeline projects. Inquire for the Report @ Goo.gle/Report . – PowerPoint PPT presentation

Number of Views:5

less

Transcript and Presenter's Notes

Title: Binge Eating Disorder Symptoms – Pipeline Overview of Therapeutics Development in H1 2017


1
Binge Eating Disorder - Pipeline Review, H1 2017
Order this report by calling 1 888 391 5441 or
Send an email to sales_at_reportsandreports.com with
your contact details and questions if any.
  • Published May 2017
  • Single User PDF US 2000

2
Binge Eating Disorder - Pipeline Review, H1 2017
  • The Market Research Report on Binge Eating
    Disorder states the symptoms and treatment for
    the eating disorders (Central Nervous System).
    The Oncology for Binge Eating Disorder is
    described in the stage of development, drug
    target, route of administration and molecule
    type. Binge eating disorder is a serious
    condition characterized by uncontrollable eating
    and resulting weight gain. The causes of
    binge-eating disorder are unknown. But family
    history, biological factors, long-term dieting
    and psychological issues increase your risk.
    Signs and symptoms include eating unusually large
    amounts of food, frequently eating alone, feeling
    that eating behavior is out of control and
    experiencing depression and anxiety. Treatment
    includes psychotherapy, medications and
    behavioral weight-loss programs.Access Complete
    Report at
  • http//www.reportsnreports.com/reports/992890-bing
    e-eating-disorder-pipeline-review-h1-2017.html.
  • Offers from 10th May 2017 to 2nd June 2017
  • All reports priced gt1,000 20 Discount
    Single User 25 Discount Global Site License.
  • Buy 2 Reports Get 1 Report Free

Order this report by calling 1 888 391 5441 or
Send an email to sales_at_reportsandreports.com with
your contact details and questions if any.
3
Binge Eating Disorder - Pipeline Review, H1 2017
  • The Pharmaceutical and Healthcare latest pipeline
    guide Binge Eating Disorder - Pipeline Review, H1
    2017, provides comprehensive information on the
    therapeutics under development for Binge Eating
    Disorder (Central Nervous System), complete with
    analysis by stage of development, drug target,
    mechanism of action (MoA), route of
    administration (RoA) and molecule type. The guide
    covers the descriptive pharmacological action of
    the therapeutics, its complete research and
    development history and latest news and press
    releases.
  • Binge Eating Disorder (Central Nervous System)
    pipeline guide helps in identifying and tracking
    emerging players in the market and their
    portfolios, enhances decision making capabilities
    and helps to create effective counter strategies
    to gain competitive advantage. The guide is built
    using data and information sourced from
    proprietary databases, company/university
    websites, clinical trial registries, conferences,
    SEC filings, investor presentations and featured
    press releases from company/university sites and
    industry-specific third party sources.
    Additionally, various dynamic tracking processes
    ensure that the most recent developments are
    captured on a real time basis.
  • Inquire for Discount http//www.reportsnreports.co
    m/contacts/discount.aspx?name992890.

Order this report by calling 1 888 391 5441 or
Send an email to sales_at_reportsandreports.com with
your contact details and questions if any.
4
Binge Eating Disorder - Pipeline Review, H1 2017
  • Scope of the Report
  • The pipeline guide provides a snapshot of the
    global therapeutic landscape of Binge Eating
    Disorder (Central Nervous System). The pipeline
    guide reviews pipeline therapeutics for Binge
    Eating Disorder (Central Nervous System) by
    companies and universities/research institutes
    based on information derived from company and
    industry-specific sources.
  • The pipeline guide covers pipeline products based
    on several stages of development ranging from
    pre-registration till discovery and undisclosed
    stages. The pipeline guide features descriptive
    drug profiles for the pipeline products which
    comprise, product description, descriptive
    licensing and collaboration details, RD brief,
    MoA other developmental activities.
  • The pipeline guide reviews key companies involved
    in Binge Eating Disorder (Central Nervous System)
    therapeutics and enlists all their major and
    minor projects. The pipeline guide evaluates
    Binge Eating Disorder (Central Nervous System)
    therapeutics based on mechanism of action (MoA),
    drug target, route of administration (RoA) and
    molecule type.
  • Buy a Copy of Report _at_ http//www.reportsnreports.
    com/purchase.aspx?name992890.

Order this report by calling 1 888 391 5441 or
Send an email to sales_at_reportsandreports.com with
your contact details and questions if any.
5
Binge Eating Disorder - Pipeline Review, H1 2017
  • Companies Involved in Therapeutics Development,
    covers
  • Chronos Therapeutics Ltd
  • F. Hoffmann-La Roche Ltd
  • Heptares Therapeutics Ltd
  • Highland Therapeutics Inc
  • Omeros Corp
  • Opiant Pharmaceuticals Inc
  • Shire Plc
  • Sunovion Pharmaceuticals Inc
  • Buy a Copy of Report _at_ http//www.reportsnreports.
    com/purchase.aspx?name992890.

Order this report by calling 1 888 391 5441 or
Send an email to sales_at_reportsandreports.com with
your contact details and questions if any.
5
6
Binge Eating Disorder - Pipeline Review, H1 2017
  • List of Tables
  • Number of Products under Development for Binge
    Eating Disorder, H1 2017
  • Number of Products under Development by
    Companies, H1 2017
  • Products under Development by Companies, H1 2017
  • Number of Products by Stage and Target, H1 2017
  • Number of Products by Stage and Mechanism of
    Action, H1 2017
  • Number of Products by Stage and Route of
    Administration, H1 2017
  • Number of Products by Stage and Molecule Type, H1
    2017
  • Binge Eating Disorder - Pipeline by Chronos
    Therapeutics Ltd, H1 2017
  • Binge Eating Disorder - Pipeline by Omeros Corp,
    H1 2017
  • Binge Eating Disorder - Pipeline by Opiant
    Pharmaceuticals Inc, H1 2017
  • Binge Eating Disorder - Pipeline by Shire Plc, H1
    2017
  • Binge Eating Disorder - Pipeline by Sunovion
    Pharmaceuticals Inc, H1 2017
  • Buy a Copy of Report _at_ http//www.reportsnreports
    .com/purchase.aspx?name992890.

Order this report by calling 1 888 391 5441 or
Send an email to sales_at_reportsandreports.com with
your contact details and questions if any.
6
7
About ReportsnReports
  • ReportsnReports.com is your single source for all
    market research needs. Our database includes
    500,000 market research reports from over 95
    leading global publishers in-depth market
    research studies of over 5000 micro markets.
  • We provide 24/7 online and offline support to our
    customers.
  • Contact
  • Ritesh Tiwari
  • Maharashtra, India.
  • Tel 1-888-391-5441
  • sales_at_reportsnreports.com
Write a Comment
User Comments (0)